Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05334069 · ClinicalTrials.gov registry record

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A clinical trial of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, sponsored by Alliance for Clinical Trials in Oncology.

Recruiting
Registry status
2,000
Enrollment target
20
Study locations

NCT05334069 is a study of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 2,000 participants, above the 109-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (1735% higher). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05334069, a study of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.

RECRUITING
Registry status
2,000 participants
Enrollment target
20
Study locations

Study Summary

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Questionnaire Administration

Study Locations (20)

Alaska

  • Anchorage Associates in Radiation Medicine - Anchorage
  • Anchorage Radiation Therapy Center - Anchorage
  • Alaska Breast Care and Surgery LLC - Anchorage
  • Alaska Oncology and Hematology LLC - Anchorage
  • Alaska Women's Cancer Care - Anchorage
  • Anchorage Oncology Centre - Anchorage
  • Katmai Oncology Group - Anchorage
  • Providence Alaska Medical Center - Anchorage
  • Fairbanks Memorial Hospital - Fairbanks

California

  • Mission Hope Medical Oncology - Arroyo Grande - Arroyo Grande
  • PCR Oncology - Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital - Bakersfield
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center - Burbank
  • Mercy Cancer Center - Carmichael - Carmichael
  • Mercy San Juan Medical Center - Carmichael
  • John Muir Medical Center-Concord - Concord

Arizona

  • Kingman Regional Medical Center - Kingman
  • Cancer Center at Saint Joseph's - Phoenix

Arkansas

  • Mercy Hospital Fort Smith - Fort Smith
  • CARTI Cancer Center - Little Rock

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2022-08-18
Est. Completion 2027-02-28

What the Registry Record Tells You About NCT05334069

The ClinicalTrials.gov registry entry for NCT05334069 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (1735% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT05334069 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Alaska, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT05334069 about?

NCT05334069 is a clinical study titled "Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection". This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early...

What is the current status of trial NCT05334069?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-08-18. Estimated completion is 2027-02-28.

What conditions does trial NCT05334069 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Gastroesophageal Junction Adenocarcinoma, Chronic Myeloid Leukemia.

What interventions are being tested in trial NCT05334069?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT05334069?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05334069 being conducted?

This trial has 20 study locations across Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.